Halting the Epidemic of Addiction and Loss Act of 2025

This bill aims to expand the scope of opioid overdose reversal agents mentioned in specific Department of Health and Human Services grant programs beyond just naloxone. Introduced in the 119th Congress as S. 2336 on July 17, 2025, the bill seeks to ensure that references to such agents are not restricted solely to naloxone, potentially broadening the types of medications or treatments eligible for consideration in relevant grant initiatives.